Cumberland Pharmaceuticals, Inc. (CPIX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.60+0.15 (+3.37%)
At close: 4:00 PM EDT
People also watch:
CRMECORTBIODALIMACUR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open4.58
Prev Close4.45
Bid0.00 x
Ask12.00 x 300
Day's Range4.55 - 4.62
52wk Range4.20 - 6.50
1y Target EstN/A
Market Cap74.64M
P/E Ratio (ttm)-460.00
Beta0.87
Volume3,472
Avg Vol (3m)11,155
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire6 days ago

    Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support

    NASHVILLE, Tenn., Aug. 23, 2016 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company focused on the development of innovative treatments for underserved patient populations, will begin distributing Ethyol® (amifostine) for injection to U.S. wholesalers today. Ethyol is an FDA approved cytoprotective drug indicated to reduce the incidence of xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer. It also reduces the cumulative renal toxicity associated with the repeated administration of cisplatin in patients with advanced ovarian cancer.

  • Capital Cube18 days ago

    ETF’s with exposure to Cumberland Pharmaceuticals, Inc. : August 11, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Cumberland Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to CPIX-US. Comparing the performance and risk of Cumberland Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
    Capital Cube20 days ago

    Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016

    Categories: Yahoo Finance Click here to see latest analysis Cumberland Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Cumberland Pharmaceuticals, Inc. – Ironwood Pharmaceuticals, Inc. Class A, DURECT Corporation, Merck & Co., Inc., Akorn, Inc., Pfizer Inc. and Sucampo Pharmaceuticals, Inc. Class A (IRWD-US, ... Read more (Read more...)